[Combined treatment with fluorinated pyrimidines and selective cyclooxygenase-2 inhibitors for liver metastasis of colon cancer].
Department of Surgical Oncology, Osaka City University Graduate School of Medicine.
Nobuo
N
Matsunaga
Nobuya
N
Yamada
Kosei
K
Hirakawa
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D003864:Depression, Chemical; D004195:Disease Models, Animal; D017308:Etodolac / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness / Q000473:pathology; D014407:Tumor Cells, Cultured
D016861:Cyclooxygenase Inhibitors; D017308:Etodolac; D005472:Fluorouracil